Conditions: Healthy
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 32
Healthy volunteers: yes

Brief summary:
The objective of the current trial is to evaluate safety, tolerability and pharmacokinetics of different multiple doses of BI 207127 BID and multiple doses of BI 207127 combined with faldaprevir in healthy male and female subjects.

Detailed description:

Arms:
arm 1: For the first 9 days patients receive BI 207127 low dose or high dose, then BI 207127 high dose with faldaprevir

Interventions: intervention 1: BI 207127 + faldaprevir
Intervention descriptions: intervention 1: fixed dose combination

Protocol document: